HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • Will Improving Adherence Optimize Medication Use?
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence and Access Marketplace
    • Visite the Marketplace
    • On-demand Webinar
  • Industry Events
    • HealthEconomics.Com Webinars
    • View Conferences
    • View Webinars
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute
You are here: Home / Archives for Economic Analysis

Bias, Credibility and Quality in Economic Evaluations

Advisory Panel Report from ISPOR […]

more info 10/24/2013View Related Articles
Bookmark and Share

Application of Healthcare Intervention Economic Evaluation

Advisory Panel report from ISPOR Working Group […]

more info 10/24/2013View Related Articles
Bookmark and Share

Quality Improvement in Pharmacoeconomic Evaluations

This link includes a great table from Mike Drummond entitled "Detecting Flaws in Economic Evaluation". Excellent student resource […]

more info 10/24/2013View Related Articles
Bookmark and Share

  • Previous Page
  • 1
  • 2
  • 3
  • 4

 

View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Conference of the Week:

Link of the Week:

Job of the Week:

Webinar of the Week:

White Papers

  • US FDA’s Emergency Use Authorization (EUA): Applicability for Marketed and/or Investigational Products for Treatment of COVID-19
  • Surprises You Don’t Want When Adopting eCOAs for Use in Clinical Trials: Cautions for Decision Making and Planning
  • Digital Approaches in the Era of COVID-19: Interviews with Science 37 and Medable
  • Evidence Generation Using Innovative, Technology-Driven Data Collection
  • Digital Therapeutics: Past Trends and Future Prospects
  • Leveraging Decentralized RWE Data Collection Strategies during the COVID-19 Pandemic and Beyond
  • The Potential Impact of Pharmaceutical and Non-Pharmaceutical Interventions to Mitigate the COVID-19 Crisis in the United States: A Model-Based Analysis
  • How to make quality metrics work for you
  • eBook: 2020-2030 | Reimagining Healthcare IT for the Next Decade
  • ISPOR Value of Information Task Force Publishes Two New Good Practices Reports
  • The Convergence of Data Analytics and Artificial Intelligence (AI) in Healthcare
  • Artificial Intelligence and Machine Learning
  • Prescription Price Transparency And The Patient Experience
  • Developing medical communications specifically for nurses
  • Protocol Design in Real-World Evidence: The Indispensable Link Between Strategic Need and Study Execution
  • Health Economics in China: Changing Pharmaceutical Pricing and Reimbursement
  • The Growing Influence of the Institute of Clinical and Economic Review on Payer Decisions in the US
  • Research Operations for Secondary Use of Clinical Sites’ EMR
  • The Role of Integrated Scientific Advice for the Early Determination of RWE Requirements in HTA and Payer Assessments
  • Pragmatic Randomized Trials: Considerations for Design and Implementation
  • Current Landscape: Value Assessment Frameworks
  • The New Health Economy is Here. Do You Have the Right Knowledge Resources in Place?
  • The Link Between Drug Prices and Research on the Next Generation of Cures
  • Social Determinants of Health: The Impact on Members, Health Outcomes and the Bottom Line
  • Leveraging Technology to Reduce Costs in Clinical Trials
  • Evidence Generation and Communication
  • Medical Cost Trend: Behind the Numbers 2020
  • Harnessing the Power of Nontraditional Data in Health Care
  • Global Oncology Trends 2019
  • Medical Affairs Reputations: Migraine (US) 2019

Syndicated Reports

  • Payer Insights on Orphan Drug Market Access
  • What do Payers Really Think About the Rising Cost of Specialty Drugs?
  • Comparing Medical Affairs Teams Head to Head
  • Building Effective Health Economic Outcomes Research (HEOR) Teams
  • Patient Reported Outcomes: Strategies for Market Access
  • Refining the Commercial Exchange Risk-Adjustment Model
  • How Can Pharma Ensure Positive Payer Support With it’s Pricing?
  • AccessPoint: Expanding the Impact of RWE
  • Market Access: Department Models and Structures
  • Do the Benefits of RBM Outweigh the Risks?
  • How do Companies Decide on PROs Delivery Mechanisms?
  • Orphan Drug Report 2014 Download
  • Download EvaluatePharma Orphan Drug Report 2015
  • Biosimilars: Regulatory Outlook
  • Final Report Released on Controversies in Obesity Management
  • Fortify Payer Relationships to Secure Product Profitability
  • Your Free Report From AIS’s Rx Benefit Data.
  • See Cutting Edge Report On Health Economics For Medical Devices Here!
  • European Payer Perspectives On Biosimilars
  • Will The Majority Of Future Drugs Meet Orphan Drug Criteria?
  • Specialty Pharmacy Trends Report: Oncology
  • Healthcare Models, Measures and Methodology – 97 FAQs
  • What Are The Greatest challenges And Opportunities For Biosimilars In Emerging Markets?
  • Market Access Policy Relationships – Comparing Germany and France
  • ASCO 2014 — Delegate Physicians Rate Influence and Impact
  • Oncology Market Access Europe – Payer and Industry Perspectives
  • Medical Affairs Reputations In Oncology: Oncologists Rate Key Products and Companies
  • The Future of Cancer Immunotherapy: KOL Views Bring Opportunities Into Sharp Focus
  • Biosimilar Index: Tracking the Biosimilar Development Landscape
  • Reshaping Medical Affairs: Delivering Value to KOLs and Payers
HealthEconomics.Com

HealthEconomics.Com

  • Become a Better Writer!
  • HealthEconomics.Com Recognized as Top Influencer at ISPOR International Meeting in Washington DC
  • Will ICER Framework Destroy Progress Against Multiple Myeloma?
  • Celgene Unleashes the Power of Data into Clinical Trial Design
  • How Well is Harvoni Working in the Real World?
  • New CVS and Express Scripts Value Based Plans for Oncology
  • Oversized Cancer Drug Vials Waste $3B Each Year
  • Can More Data Make Providers’ Jobs Easier?
  • News
  • Conferences
  • Reports
  • Jobs
  • Consulting
  • Newsletters
  • White Papers

More Links

  • Take This Survey for a Chance to Win $200!
  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • ICER Releases Two Draft Reports on Obeticholic Acid
  • What do Patient Advocates Think of New ICER Report?
  • Could a New ICER Report Put Patients at Risk?
  • Contact Us

About

  • International Myeloma Foundation Responds to ICER Report
  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HE Institute

Strategy, Training, Education, and Communications in HEOR & Market Access.

Innovation Webinar

Big ideas accelerating change in HEOR, RWE and Health Technology. Learn more!

tHEORetically Speaking Blog

Insights and observations for HEOR, market access, pricing, reimbursement, and health policy.

HE Jobs Portal

Your Premier Employment Source for HEOR, Market Access, and Real World Evidence

HE Webinars

Online educational and informational seminars for HEOR, market access, pricing, and reimbursement.
  • Doctor Evidence Launches GROWTH Replicator Program
  • Is PCORI Underfunding CER?
  • HealthEconomics.Com
  • About HealthEconomics.Com
  • Advertising Inquiries
  • Careers
  • Contact HealthEconomics.Com

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • Will Improving Adherence Optimize Medication Use?
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence and Access Marketplace
    • Visite the Marketplace
    • On-demand Webinar
  • Industry Events
    • HealthEconomics.Com Webinars
    • View Conferences
    • View Webinars
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute